ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,618.26
      -0.29%
      US Tech 100
      19,197.60
      1.80%
      Dow Jones
      41,503.10
      -0.25%
      Brent Oil
      73.995
      2.23%
      Bitcoin
      62,064.12
      0.64%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE

      6. KV Pharmaceutical Co. CL B (KV.B) Quote

      KV Pharmaceutical Co. CL B

      KV Pharmaceutical Co. CL B (KV.B)

      NYSE
      0.41
      0.00
      (0.00%)
      Closed September 18 4:00PM
      Delayed by 15 minutes
      0.41
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.41
      Bid
      -
      Ask
      -
      Volume
      0.00
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Previous Close
      0.41
      Open
      -
      Last Trade
      Last Trade Time
      -
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      KV.B Latest News

      More News

      FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

      19 hours ago

      KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million Recapitalization

      KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million Recapitalization Company Positioned For Further Growth With Focus On Products Serving...

      September 16 2013
      PR Newswire (US)

      Ther-Rx Corporation and Perrigo Company Announce the Availability of Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%...

      Ther-Rx Corporation and Perrigo Company Announce the Availability of Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%) for Prescribing /* Style Definitions...

      January 24 2013
      PR Newswire (US)

      K-V Pharmaceutical Receives Court Approval of Hologic Settlement

      K-V Pharmaceutical Receives Court Approval of Hologic Settlement /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prne...

      December 28 2012
      PR Newswire (US)

      K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of P...

      K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of Plan of Reorganization /* Style Definitions...

      December 12 2012
      PR Newswire (US)

      K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy Court

      K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy Court Follows Agreement Between the Company and Its Senior Note Holders Regarding Cash Collateral PR Newswire ST. LOUIS...

      August 10 2012
      PR Newswire (US)

      K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy Court

      K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy Court PR Newswire ST. LOUIS, Aug. 8, 2012 ST. LOUIS, Aug. 8, 2012 /PRNewswire/ -- K-V Pharmaceutical Company ("K-V" or "the...

      August 08 2012
      PR Newswire (US)

      K-V Pharmaceutical Class A and Class B Common Stock Begin Trading on the OTC Markets

      K-V Pharmaceutical Class A and Class B Common Stock Begin Trading on the OTC Markets PR Newswire ST. LOUIS, Aug. 7, 2012 ST. LOUIS, Aug. 7, 2012 /PRNewswire/ -- K-V Pharmaceutical Company ("K-V...

      August 07 2012
      PR Newswire (US)

      K-V Pharmaceutical Announces Planned Transition of Trading of Class A and Class B Common Shares to the OTC Markets

      K-V Pharmaceutical Announces Planned Transition of Trading of Class A and Class B Common Shares to the OTC Markets PR Newswire ST. LOUIS, Aug. 6, 2012 ST. LOUIS, Aug. 6, 2012 /PRNewswire/ -- K-V...

      August 06 2012
      PR Newswire (US)

      K-V Pharmaceutical Company Files Voluntary Petitions for Reorganization to Restructure Financial Obligations

      K-V Pharmaceutical Company Files Voluntary Petitions for Reorganization to Restructure Financial Obligations Company continues to operate its businesses and serve the needs of healthcare...

      August 04 2012
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DE
      40000000DE
      120000000DE
      260000000DE
      520000000DE
      1560000000DE
      2600000000DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MANUManchester United Plc
      $ 17.75
      (9.91%)
      		12
      SMHISEACOR Marine Holdings Inc
      $ 10.95
      (8.52%)
      		3
      STEMStem Inc
      $ 0.4799
      (7.38%)
      		1
      MNSOMINISO Group Holding Limited
      $ 16.25
      (7.33%)
      		9.13k
      EXKEndeavour Silver Corporation
      $ 3.71
      (7.23%)
      		9.57k
      SCSSteelcase Inc
      $ 12.85
      (-8.93%)
      		2.1k
      EGOEldorado Gold Corp Ltd
      $ 16.23
      (-4.87%)
      		500
      NRDYNerdy Inc
      $ 1.01
      (-4.72%)
      		129
      ANVSAnnovis Bio Inc
      $ 7.97
      (-4.67%)
      		1
      SOSSOS Limited
      $ 0.60
      (-3.57%)
      		2
      NIONIO Inc
      $ 5.25
      (4.58%)
      		447.97k
      BABAAlibaba Group Holding Limited
      $ 87.98
      (4.22%)
      		128.73k
      RIORio Tinto Plc
      $ 65.32
      (3.83%)
      		111.74k
      PLTRPalantir Technologies Inc
      $ 37.15
      (2.12%)
      		96.34k
      XPEVXPeng Inc
      $ 9.10
      (5.32%)
      		81.33k

      KV.B Discussion

      View Posts
      mikemar mikemar 14 years ago
      Would be concerned to own a stock that just embarrassed the government (FDA) and charities (MOD) at the same time as outraging the public through the Makena pricing. Would wonder where the hammer is going to fall on this organization and from who especially given its past criminal issues. Looking for competitor that would benefit most in a year if KV is out of business. Possibly Watson Pharmaceuticals. If they are smart enough to play this right they could make a tidy profit with there Makena alternative while looking like heroes compated to KV
      👍️0
      USMC_COMBAT_VET USMC_COMBAT_VET 14 years ago
      Wish I bought in at .70 but still bought at good price. Nice stock and I bet it will go over $20
      👍️0
      Blade$dream Blade$dream 14 years ago
      LET THE FREE SHARES RUN LEMN
      👍️0
      ventrikel ventrikel 14 years ago
      Yes, we could make big gains.
      I suggest its possible.

      Near the "power-zone", if resistance could be broken at 3,40
      we would have blue sky.
      👍️0
      Blade$dream Blade$dream 14 years ago
      the half of value from year 07 and I'm a happy man!
      👍️0
      ventrikel ventrikel 14 years ago
      Yes, and it looks like they go the way back to the 07`highs.
      Bought in yesterday and will rebuy on any dip.
      But be careful, the spread is wide.

      Good luck.
      👍️0
      Stock Stock 14 years ago
      yes: http://investorshub.advfn.com/boards/board.aspx?board_id=14752
      👍️0
      Blade$dream Blade$dream 14 years ago
      can annyone find this company?
      👍️0

      Your Recent History

      NYSE
      KV.B
      K V Pharma
      Delayed Upgrade Clock